Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Both are available in injectable and oral formats
Ironwood Pharmaceuticals Sector: Pharmaceuticals, with a focus on GI and rare diseases HQ: 100 Summer St, Suite 2300, Boston, MA Year Founded: 1998 Key Leaders: Thomas McCourt, CEO Number of Employees: 200300 Stage: Public Financial Snapshot: $540 million market cap Notable Investors: The Vanguard Group, BlackRock, Armistice Capital Key Products: Ironwood markets Linzess (linaclotide) for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC)
Sn phm ph hp vi ngi trng thnh mun b sung glutathione hm lng cao
Now, they hold FDA approval for helping individuals manage their weight
Prospective patients should be confident knowing the clinician will oversee your specific case, prescribing the right dose, providing the necessary instructions to get started, and adjusting your dose throughout your care plan
Quality sleep supports muscle recovery
